...
首页> 外文期刊>Chemical Week >Pfizer eyes AstraZeneca for reported $101 billion
【24h】

Pfizer eyes AstraZeneca for reported $101 billion

机译:辉瑞斥资1010亿美元收购阿斯利康

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A recent UK press report says that Pfizer has made initial approaches to acquire AstraZeneca for £60 billion ($101 billion) in what would.be the world's largest pharmaceutical acquisition. The two companies have declined to comment on the report, which appeared in The Sunday Times. A deal between Pfizer and AstraZeneca would create one of the top 10 companies worldwide by market value. AstraZeneca has rejected Pfiz-er's overtures, according to the report.
机译:英国最近的一份新闻报道称,辉瑞已采取初步措施以600亿英镑(1,010亿美元)的价格收购阿斯利康,这将成为全球最大的药品收购。两家公司均拒绝对《星期日泰晤士报》上的报道发表评论。辉瑞与阿斯利康之间的交易将创造出按市值计算的全球十大公司之一。该报告称,阿斯利康拒绝了菲菲泽尔的提议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号